Trials / Completed
CompletedNCT02214693
PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients
A Clinical Study to Investigate the Pharmacokinetics/Pharmacodynamics and Tolerability of DA-1229(Evogliptin) Tablet in Renal Impaired Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This is a clinical study to investigate the pharmacokinetics/pharmacodynamics and tolerability of DA-1229(Evogliptin) tabletin renal impaired patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-1229 |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-03-01
- First posted
- 2014-08-12
- Last updated
- 2015-08-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02214693. Inclusion in this directory is not an endorsement.